JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|
|||
| 192 | Mon, 8/1/2011, 12:30 PM - 1:50 PM | CC-JR Ballroom D | |
| Biopharmaceutical Section P.M. Roundtable Discussions (fee event) — Roundtables PM Roundtable Discussion | |||
| Biopharmaceutical Section | |||
| Organizer(s): Carmen Mak, Schering Plough Research Institute | |||
| ML10: | Implementation and Logistics of Adaptive Trial Design — Eva R. Miller, ICON Clinical Research | ||
| ML11: | Statistical Issues in the Design and Analysis of Dose-Response Studies — Susan Huyck, Merck Research Laboratories | ||
| ML12: | Effect of Subsequent Therapies After Discontinuation of Study Medication in Analyzing Overall Survival in Cancer Clinical Trials — Julie Xiuyu Cong, Boehringer Ingelheim | ||
| ML13: | Analysis of Longitudinal Categorical Data — Madhuja Mallick, Merck Research Laboratories | ||
| ML14: | CANCELLED: Impact of the Noninferiority Clinical Trials Draft FDA Guidance on Noninferiority Margins Interpretation — Claude Petit, Boehringer Ingelheim | ||
| ML15: | Health Care Reform, Baby Boomers, and the Pharmaceutical Industry — T. Paulette Ceesay, Merck & Co., Inc. ; Darcy Hille, Merck & Co., Inc. | ||
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.